Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trialPascal Vranckx, Ángel Cequier, Gerrit Anne van Es et al.|The Lancet|2018Cited by 793
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trialJaved Butler, Imran Zainal Abidin, Ciaran J. McMullan et al.|The Lancet|2025Cited by 77
Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS TrialFelice Gragnano, Pedro Canas da Silva, Marcel Zwahlen et al.|Journal of the American Heart Association|2022Cited by 12